Hengrui Pharmaceuticals Repurchases 74 Million Yuan of Shares Under Buyback Plan

MT Newswires Live11-03

Jiangsu Hengrui Pharmaceuticals (SHA:600276) repurchased around 1.6 million A-shares for a total of 73.9 million yuan as of Oct. 31 under its share buyback program.

The repurchased shares account for 0.025% of the company's total share capital, according to a Tuesday filing with the Shanghai bourse. The purchase prices ranged from 43.10 yuan to 46.33 yuan per share.

In October alone, the company bought back about 1.1 million shares for 48.0 million, at prices ranging from 44.80 yuan to 46.33 yuan per share.

Hengrui launched the buyback plan in August, with a total repurchase target of 1 billion yuan to 2 billion yuan. It intends to use the repurchased shares for an employee stock ownership plan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment